BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35293439)

  • 1. Perspectives for a new drug candidate for Chagas disease therapy.
    Soeiro MNC
    Mem Inst Oswaldo Cruz; 2022; 117():e220004. PubMed ID: 35293439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current trends in the pharmacological management of Chagas disease.
    Ribeiro V; Dias N; Paiva T; Hagström-Bex L; Nitz N; Pratesi R; Hecht M
    Int J Parasitol Drugs Drug Resist; 2020 Apr; 12():7-17. PubMed ID: 31862616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Biological in vitro and in vivo Evaluation of 2-(5-Nitroindazol-1-yl)ethylamines and Related Compounds as Potential Therapeutic Alternatives for Chagas Disease.
    Martín-Escolano R; Aguilera-Venegas B; Marín C; Martín-Montes Á; Martín-Escolano J; Medina-Carmona E; Arán VJ; Sánchez-Moreno M
    ChemMedChem; 2018 Oct; 13(19):2104-2118. PubMed ID: 30098232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, Design, and Structure-Activity Relationship of a Benzenesulfonylpiperazine Series against Trypanosoma cruzi.
    Cassiano Martinho AC; de Melo Resende D; Landin ES; Dit Lapierre TJWJ; Bernardes TCD; Martins LC; Ferreira RS; Murta SMF; de Oliveira Rezende Júnior C
    ChemMedChem; 2022 Oct; 17(19):e202200211. PubMed ID: 35993440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current advances in drug discovery for Chagas disease.
    Scarim CB; Jornada DH; Chelucci RC; de Almeida L; Dos Santos JL; Chung MC
    Eur J Med Chem; 2018 Jul; 155():824-838. PubMed ID: 30033393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Therapeutic Options for Chagas Disease Based on Bioactive Compounds from Algae, Bacteria and Fungi Species.
    da Silva MV; Gondim BLC; de Carvalho-Costa TM; Mendes MT; Lemes MR; Barbosa RM; Cardoso TN; Nascimento NS; Barros DB; da Silva MV; Machado JR; Castellano LRC
    Curr Med Chem; 2021; 28(36):7513-7528. PubMed ID: 34365936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection.
    Barbosa JMC; Pedra Rezende Y; de Melo TG; de Oliveira G; Cascabulho CM; Pereira ENGDS; Daliry A; Salem KS
    Microbiol Spectr; 2022 Feb; 10(1):e0185221. PubMed ID: 35138142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies.
    Soeiro Mde N; Dantas AP; Daliry A; Silva CF; Batista DG; de Souza EM; Oliveira GM; Salomão K; Batista MM; Pacheco MG; Silva PB; Santa-Rita RM; Barreto RF; Boykin DW; Castro SL
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():301-10. PubMed ID: 19753489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chagas Disease Chemotherapy: What Do We Know So Far?
    Zuma AA; de Souza W
    Curr Pharm Des; 2021; 27(38):3963-3995. PubMed ID: 33593251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target-based Screening of the Chagas Box: Setting Up Enzymatic Assays to Discover Specific Inhibitors Across Bioactive Compounds.
    Salas-Sarduy E; Niemirowicz GT; José Cazzulo J; Alvarez VE
    Curr Med Chem; 2019; 26(36):6672-6686. PubMed ID: 31284853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
    Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening.
    Melo-Filho CC; Braga RC; Muratov EN; Franco CH; Moraes CB; Freitas-Junior LH; Andrade CH
    Eur J Med Chem; 2019 Feb; 163():649-659. PubMed ID: 30562700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease.
    Wong-Baeza C; Nogueda-Torres B; Serna M; Meza-Toledo S; Baeza I; Wong C
    BMC Pharmacol Toxicol; 2015 Apr; 16():10. PubMed ID: 25896924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo activity of the chloroaryl-substituted imidazole viniconazole against Trypanosoma cruzi.
    Silva CF; Batista Dda G; Batista MM; Lionel J; Hammer ER; Brun R; Soeiro Mde N
    Parasitology; 2014 Mar; 141(3):367-73. PubMed ID: 24553079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model.
    Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F
    Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.
    Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G
    Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing strategies for Chagas disease therapy: the effect of imatinib and derivatives against Trypanosoma cruzi.
    Simões-Silva MR; De Araújo JS; Peres RB; Da Silva PB; Batista MM; De Azevedo LD; Bastos MM; Bahia MT; Boechat N; Soeiro MNC
    Parasitology; 2019 Jul; 146(8):1006-1012. PubMed ID: 30859917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of statins on inflammation and cardiac function in patients with chronic Chagas disease: A protocol for pathophysiological studies in a multicenter, placebo-controlled, proof-of-concept phase II trial.
    Campos-Estrada C; Urarte E; Denegri M; Villalón L; González-Herrera F; Kemmerling U; Maya JD
    PLoS One; 2023; 18(1):e0280335. PubMed ID: 36638112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic and bioinformatic analysis of Trypanosoma cruzi chemotherapy and potential drug targets: new pieces for an old puzzle.
    Sadok Menna-Barreto RF; Belloze KT; Perales J; Silva FP
    Curr Drug Targets; 2014 Mar; 15(3):255-71. PubMed ID: 24041335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Approaches for the Treatment of Chagas Disease.
    Pandey RP; Nascimento MS; Moore CE; Raj VS; Kalil J; Cunha-Neto E
    Curr Drug Targets; 2021; 22(7):835-841. PubMed ID: 33238855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.